Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia.

Manschreck TC, Redmond DA, Candela SF, Maher BA.

J Neuropsychiatry Clin Neurosci. 1999 Fall;11(4):481-9.

PMID:
10570762
2.

The effects of clozapine on cognitive functioning in schizophrenia.

McGurk SR.

J Clin Psychiatry. 1999;60 Suppl 12:24-9. Review.

3.

Effects of clozapine on cognitive function in schizophrenia.

Lee MA, Thompson PA, Meltzer HY.

J Clin Psychiatry. 1994 Sep;55 Suppl B:82-7. Review.

PMID:
7961582
4.

Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies.

Goldberg TE, Weinberger DR.

J Clin Psychiatry. 1996;57 Suppl 9:62-5. Review.

PMID:
8823353
6.

[Clozapine: neuropsychological and neuroimaging studies].

Pérez-Gómez M, Junqué C.

Actas Esp Psiquiatr. 1999 Sep-Oct;27(5):341-6. Review. Spanish.

PMID:
10545667
7.

The effects of clozapine on neurocognition: an overview.

Goldberg TE, Weinberger DR.

J Clin Psychiatry. 1994 Sep;55 Suppl B:88-90. Review.

PMID:
7525543
8.

The effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptoms.

Brar JS, Chengappa KN, Parepally H, Sandman AR, Kreinbrook SB, Sheth SA, Ganguli R.

Ann Clin Psychiatry. 1997 Dec;9(4):227-34. Review.

PMID:
9511946
9.
10.

Cognitive effects of conventional and atypical antipsychotics in schizophrenia.

Sharma T.

Br J Psychiatry Suppl. 1999;(38):44-51. Review. No abstract available.

PMID:
10884899
11.

Effectiveness of clozapine in hospitalised people with chronic neuroleptic-resistant schizophrenia.

Avnon M, Rabinowitz J.

Br J Psychiatry. 1995 Dec;167(6):760-4. Review.

PMID:
8829743
12.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
13.

A systematic review of the evidence of clozapine's anti-aggressive effects.

Frogley C, Taylor D, Dickens G, Picchioni M.

Int J Neuropsychopharmacol. 2012 Oct;15(9):1351-71. doi: 10.1017/S146114571100201X. Epub 2012 Feb 20. Review.

PMID:
22339930
14.

Management of schizophrenia in children and adolescents. The role of clozapine.

Remschmidt H, Fleischhaker C, Hennighausen K, Schulz E.

Paediatr Drugs. 2000 Jul-Aug;2(4):253-62. Review.

PMID:
10946414
15.

Classics in chemical neuroscience: clozapine.

Wenthur CJ, Lindsley CW.

ACS Chem Neurosci. 2013 Jul 17;4(7):1018-25. doi: 10.1021/cn400121z. Review.

16.
17.

Progress in defining optimal treatment outcome in schizophrenia.

Remington G, Foussias G, Agid O.

CNS Drugs. 2010 Jan;24(1):9-20. doi: 10.2165/11530250-000000000-00000. Review.

PMID:
20030416
18.

The NEWMEDS rodent touchscreen test battery for cognition relevant to schizophrenia.

Hvoslef-Eide M, Mar AC, Nilsson SR, Alsiö J, Heath CJ, Saksida LM, Robbins TW, Bussey TJ.

Psychopharmacology (Berl). 2015 Nov;232(21-22):3853-72. doi: 10.1007/s00213-015-4007-x. Epub 2015 Jul 24. Review.

PMID:
26202612
19.

Drugs of the psychopharmacological revolution in clinical psychiatry.

Lieberman JA, Golden R, Stroup S, McEvoy J.

Psychiatr Serv. 2000 Oct;51(10):1254-8. Review. No abstract available.

PMID:
11013323
20.

From Clozapine to Cognitive Remediation.

Quinn J, Kolla NJ.

Can J Psychiatry. 2017 Feb;62(2):94-101. doi: 10.1177/0706743716656830. Epub 2016 Jul 10. Review.

Supplemental Content

Support Center